INTRODUCTION
Charcoal is used for localization of a non-palpable breast mass.
Although charcoal is known to be safe when injected subcutaneously for preoperative localization, it can cause a foreign body re- 
CASE REPORT
A 60-year-old woman visited our hospital for a routine breast exam. She had no palpable lesion in the breast. However, a 0.9 cm mass with an indistinct margin was detected in the left lower outer quadrant of the breast by mammography (Fig. 1A) . US Charcoal remains stable without causing a foreign body reaction and it may be used for preoperative localization of a non-palpable breast mass. However, cases of postcharcoal-marking granuloma have only rarely been reported in the breast, and a charcoal granuloma can be misdiagnosed as malignancy. Herein, we report the ultrasound, computed tomography (CT), 18F-fluorodeoxyglucose-positron emission tomography/CT, and breast-specific gamma imaging findings of recurrence-mimicking charcoal granuloma after breast conserving surgery, following localization with charcoal in a breast cancer patient.
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J Korean Soc Radiol 2016;75(1):57-61 tem 4 (Fig. 1B) . Because she was aware of the presence of a previous, probably benign mass in her breast, she opted for excision of the mass. Therefore, preoperative US-guided localization was performed using charcoal. A mixture of 1 mL charcoal (Charcotrace; Phebra, Sydney, Australia) and 1 mL normal saline was On the second follow-up US performed 12 months after surgery, significant change was not detected in the spiculated irregular hypoechoic lesion in the left breast (Fig. 2C) . Chest CT showed that the lesion was an ovoid hyperdense (47-66 Hounsfield units) mass with adjacent postoperative distortion, which did not significantly enhance after contrast administration (Fig. 2D) . On FDG-PET/CT, a newly developed hypermetabolic lesion (maximum standardized uptake value = 2.6-3.7) was noted in the previous operative bed in the left middle outer quadrant of the breast (Fig. 2E) . Based on the suspicion of recurrence, a US-guided biopsy was performed using a 14-gauge semi-automated core biopsy needle (Stericut; TSK, Tochigi, Japan). The gross specimens were dark-pigmented soft-tissue fragments (Fig. 3A) . Histologic evaluation revealed extensive charcoal deposits and multinucleated giant cells with surrounding granulomatous inflammation, but no malignant cells (Fig. 3B) .
The patient' s follow-up US, PET/CT, and BSGI over the course of three years revealed no significant interval change in the lesion.
DISCUSSION
Several cases of malignancy-mimicking granuloma of the breast following charcoal marking have been reported, but only However, to the best of our knowledge, BSGI findings of a charcoal granuloma have not yet been reported. BSGI is a radioisotopic imaging modality that is emerging as a useful complementary tool to diagnose breast cancer when more information is needed after questionable initial radiological findings (7). BSGI is based on the increased uptake of Tc-sestamibi uptake (9).
Charcoal is usually used to localize a non-palpable breast mass and is a biologically inert material when injected subcutaneously, but it can remain in situ for up to 60 days without causing a foreign body reaction (1). However, an experimental study reported that charcoal particles are ingested by macrophages and are very slowly carried away from the injection site, causing inflammation (10) . In fact, charcoal remaining in the surgical bed could facilitate an inflammatory reaction during postoperative healing.
In the present case, our patient was injected with charcoal twice (> 1 mL) and received radiotherapy after surgery, possibly resulting in a synergistic effect leading to the charcoal granuloma (6).
It is difficult to distinguish tumor recurrence from a benign lesion such as a postoperative change or charcoal granuloma using US, FDG-PET/CT, CT or BSGI alone. CT can be somewhat helpful due to hyperattenuation of a charcoal granuloma. A US-guided core-needle biopsy can be effective in obtaining a better diagnosis.
In summary, we reported US, CT, FDG-PET/CT and BSGI findings of a charcoal granuloma discovered in the breast after breast-conserving surgery. Charcoal granuloma should be included in the differential diagnosis of incidentally detected le- 
